New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee UK Haemophilia Directors' Organisation.
Ludlam
C A
CA
D007562:Creutzfeldt-Jakob Syndrome / Q000635:transmission*; D005169:Factor VIII / Q000009:adverse effects / Q000627:therapeutic use; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D012307:Risk Factors
D011994:Recombinant Proteins; D005169:Factor VIII